Using machine learning (ML) and explainable artificial intelligence (AI) to accurately predict immune-checkpoint inhibitor (ICI) response in small cell (SCLC) and non-small cell (NSCLC) lung cancer patients

Sharma, L., Balaji, V., Katumba, A., Mohan, E., Mporas, I., Alrifai, D., Chow, J., Sevitt, T., Nathan, K., Shah, R., Waters, J.S.C. and Adeleke, S. (2025) Using machine learning (ML) and explainable artificial intelligence (AI) to accurately predict immune-checkpoint inhibitor (ICI) response in small cell (SCLC) and non-small cell (NSCLC) lung cancer patients. ESMO Open, 10 (Supple): 104157-2P. ISSN 2059-7029
Copy
Item Type Article
Additional information © 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the Creative Commons Attribution Non-Commercial No-Derivatives CC BY-NC-ND licence, https://creativecommons.org/licenses/by-nc-nd/4.0/
Date Deposited 15 May 2025 15:52
Last Modified 15 May 2025 15:52

Explore Further

picture_as_pdf
picture_as_pdf
1-s2.0-S2059702925000250-main.pdf
subject
Published Version
Available under Creative Commons: BY-NC-ND 4.0
View Download

Atom BibTeX OpenURL ContextObject in Span OpenURL ContextObject Dublin Core MPEG-21 DIDL EndNote HTML Citation METS MODS RIOXX2 XML Reference Manager Refer ASCII Citation
Export

Downloads